Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival
Eva M. Medina‐Rodríguez(Hospital Universitario Doctor Peset), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Ana Bribián(Consejo Superior de Investigaciones Científicas), Francisco Javier Arenzana(Hospital Nacional de Parapléjicos), Rafael G. Sola(Hospital Universitario de La Princesa), Carmen Gil(Instituto de Salud Carlos III), Jesús Pastor(Hospital Universitario de La Princesa), Miriam Redondo(Instituto de Química Médica)
Cited by 57
Related Papers
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
|Medicinal Research Reviews|2002|334
TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
|Brain Behavior and Immunity|2018|293